Literature DB >> 21221353

Hepatitis B Infection in Canada: Epidemiology and implications for control.

G Delage, A O Carter.   

Abstract

A review of Canadian surveillance data for the past decade indicates that the incidence of reported hepatitis B cases has increased despite the availability of safe and effective vaccine. Sexual transmission (particularly heterosexual transmission) is the major route of virus spread in North America. Because of this fact, and because immunization of selected high-risk groups has failed to control disease, universal immunization is the strategy of choice.

Entities:  

Year:  1992        PMID： 21221353      PMCID： PMC2145899     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


  28 in total

1.  Hepatitis B vaccine appears headed for pediatric immunization schedule.

Authors:  C Marwick
Journal:  JAMA       Date:  1991-03-27       Impact factor: 56.272

Review 2.  Immunology of hepatitis B virus infection.

Authors:  G J Alexander
Journal:  Br Med Bull       Date:  1990-04       Impact factor: 4.291

Review 3.  The emergence of hepatitis B as a sexually transmitted disease.

Authors:  M J Alter; H S Margolis
Journal:  Med Clin North Am       Date:  1990-11       Impact factor: 5.456

4.  Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis.

Authors:  M J Alter; P J Coleman; W J Alexander; E Kramer; J K Miller; E Mandel; S C Hadler; H S Margolis
Journal:  JAMA       Date:  1989-09-01       Impact factor: 56.272

5.  Comparison of a recombinant DNA hepatitis B vaccine alone or in combination with hepatitis B immune globulin for the prevention of perinatal acquisition of hepatitis B carriage.

Authors:  Y Poovorawan; S Sanpavat; W Pongpunlert; S Chumdermpadetsuk; P Sentrakul; S Chitinand; R Sakulramrung; Y Tannirundorn
Journal:  Vaccine       Date:  1990-03       Impact factor: 3.641

6.  Success of a program of routine prenatal screening for hepatitis B surface antigen: the first 2 years.

Authors:  N B Okun; R P Larke; J R Waters; M R Joffres
Journal:  CMAJ       Date:  1990-12-15       Impact factor: 8.262

7.  Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma.

Authors:  E Kaklamani; D Trichopoulos; A Tzonou; X Zavitsanos; Y Koumantaki; A Hatzakis; C C Hsieh; S Hatziyannis
Journal:  JAMA       Date:  1991-04-17       Impact factor: 56.272

8.  The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies.

Authors:  M J Alter; S C Hadler; H S Margolis; W J Alexander; P Y Hu; F N Judson; A Mares; J K Miller; L A Moyer
Journal:  JAMA       Date:  1990-03-02       Impact factor: 56.272

9.  Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population.

Authors:  R B Wainwright; B J McMahon; L R Bulkow; D B Hall; M A Fitzgerald; A P Harpster; S C Hadler; A P Lanier; W L Heyward
Journal:  JAMA       Date:  1989-04-28       Impact factor: 56.272

10.  Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program.

Authors:  Y J Tsen; M H Chang; H Y Hsu; C Y Lee; J L Sung; D S Chen
Journal:  J Med Virol       Date:  1991-06       Impact factor: 2.327
View more
  2 in total

1.  Moving towards a universal hepatitis B vaccine program for Canadian children.

Authors:  N Macdonald
Journal:  Can J Infect Dis       Date:  1995-05

2.  Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada.

Authors:  Carla S Coffin; Scott K Fung; Fernando Alvarez; Curtis L Cooper; Karen E Doucette; Claire Fournier; Erin Kelly; Hin Hin Ko; Mang M Ma; Steven R Martin; Carla Osiowy; Alnoor Ramji; Edward Tam; Jean Pierre Villeneuve
Journal:  Can Liver J       Date:  2018-12-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.